High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma
Article
Schulze, Arik Bernard
, Kuntze, Anna, Schmidt, Lars Henning, Mohr, Michael, Marra, Alessandro , Hillejan, Ludger, Schulz, Christian, Görlich, Dennis, Hartmann, Wolfgang, Bleckmann, Annalen and Evers, Georg
(2022)
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma.
Cancers 14 (6), p. 1395.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cancers | ||||
| Publisher | MDPI | ||||
| Place of Publication | BASEL | ||||
| Volume | 14 | ||||
| Number of Issue or Book Chapter | 6 | ||||
| Page Range | p. 1395 | ||||
| Date | 2022 | ||||
| Date of publication | 29 Feb 2024 12:58 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin II | ||||
| Identification Number |
| ||||
| Keywords | CELL LUNG-CANCER; DABRAFENIB PLUS TRAMETINIB; OPEN-LABEL; METASTASIS; CRIZOTINIB; ALK; NSCLC; TP53; p53; NT5DC2; CAFs | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 57598 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric